PRTC•benzinga•
PureTech Founded Entity Seaport Therapeutics Announces Publication Of Research Demonstrating Increased Lymphatic Transport With Up To 55% Drug Absorption Via Lymphatics With GlyphTM Platform
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 12, 2025 by benzinga